Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABT
GILD
Add up to 3 more stocks
ABT
Abbott Laboratories
-1.35%
$101.96-1.40Delayed quote: Sep 11, 2026, 3:59 PM EDT
Market Cap
$176.43B
52W Range
$81.97 - $137.49
GILD
Gilead Sciences, Inc.
-0.75%
$143.72-1.09Delayed quote: Sep 11, 2026, 4:00 PM EDT
Market Cap
$178.44B
52W Range
$108.46 - $157.29
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 32.78 | N/A |
| Forward P/E | 18.48 | N/A |
| P/B Ratio | 3.45 | 15.09 |
| P/S Ratio | 3.79 | 5.86 |
| P/FCF Ratio | 22.27 | 13.76 |
| EV/EBITDA | 18.73 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 56.8% | 79.6% |
| Operating Margin | 17.0% | 39.7% |
| Net Margin | 11.7% | -10.6% |
| ROE | 10.6% | -27.4% |
| ROA | 5.0% | -6.6% |
| ROIC | 6.1% | -3.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.38 | 1.27 |
| Quick Ratio | 0.97 | 1.09 |
| Debt/Equity | 0.64 | 2.22 |
| Interest Coverage | 23.60 | 11.43 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.4% | 2.2% |
| Payout Ratio | 79.7% | N/A |
| Yrs of Dividend Growth | 52 | 10 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.